Latest News
Conference Coverage
Plecanatide improves bowel function, abdominal pain
CHICAGO – Now approved for chronic idiopathic constipation, plecanatide has been presented for a supplemental new drug application for adult IBS-C...
Feature
New heart failure guidelines prioritize prevention
The latest update to U.S. guidelines for heart failure management, released at the end of April , puts unprecedented emphasis on heart failure...
Conference Coverage
Study links photosensitizing antihypertensives to SCC
PORTLAND, ORE. - The results have implications for skin cancer screening and prevention for patients on these drugs.
From the Journals
Dual-task walking test may be effective dementia predictor
Dual-task gait testing can be an accurate, low-cost method of predicting progression to dementia in patients with mild cognitive impairment.
Conference Coverage
Marijuana-related visits to Colorado ED steadily increasing
ED and urgent care visits related to cannabis among teens in Colorado doubled from 2009 to 2015.
From the Journals
Alternating therapy in renal cell carcinoma fails to show an advantage
Everolimus alternating with pazopanib and pazopanib alone were compared in a randomized, multicenter controlled trial.
From the Journals
Strength plus aerobics equals fitness for obese older adults
Scores for a combination plan improved significantly more than either an aerobic exercise or resistance exercise plan.
From the Journals
Imatinib cuts mast cells in severe asthma
In a trial, imatinib decreased airway mast-cell counts and airway hyperresponsiveness in adults with asthma, who were not responding well to...
From the Journals
Mepolizumab proves effective for eosinophilic granulomatosis with polyangiitis
The anti–interleukin-5 monoclonal antibody beat placebo for total accrued weeks of remission and remission after 36 and 48 weeks of treatment.
Conference Coverage
More early-stage cancer diagnosis since ACA implementation
Though the increase is small, cancer has been detected earlier and more often, indicating future improvements in care.
From the Journals
Adalimumab outperforms methotrexate in treating severe pediatric plaque psoriasis
A phase III study provided promising data on the efficacy of adalimumab in children and adolescents with severe plaque psoriasis.